Tech Company Financing Transactions
Rincon Pharmaceuticals Funding Round
Rincon Pharmaceuticals secured a $4.7 million investment round on 11/15/2005. Backers included Paperboy Ventures.
Transaction Overview
Company Name
Announced On
11/15/2005
Transaction Type
Venture Equity
Amount
$4,700,000
Round
Undisclosed
Investors
Paperboy Ventures (Carolyn Patrick)
Proceeds Purpose
With this financing Rincon will accelerate its development of protein therapeutics and scale-up of its manufacturing capability.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
3030 Bunker Hill Street 318
San Diego, CA 92109
USA
San Diego, CA 92109
USA
Phone
Website
Email Address
Overview
Rincon Pharmaceuticals is a San Diego-based biopharmaceuticals company using eukaryotic algae to produce human therapeutic proteins, especially monoclonal antibodies. Rincon's mission is to increase the availability of protein-based therapeutics by dramatically decreasing the time and cost of developing complex recombinant proteins.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bruce Steel
Chief Scientific Officer
Peter Heifetz
Browse more venture capital transactions:
Prev: 11/15/2005: Trilogy Studios venture capital transaction
Next: 11/15/2005: Metara venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs